VFA
KYNB

Virtus Fund Advisers’s Kyntra Bio KYNB Stock Holding History

Virtus Fund Advisers’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$405K Buy
+342
New +$429K ﹤0.01% 349

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Virtus Fund Advisers's KYNB Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Kyntra Bio (KYNB) in Q4 2017: 342 shares worth $405K. The stake represents ﹤0.01% of the portfolio and ranks #349 among its holdings.

187 funds tracked by Wall St. Rank hold KYNB as of Q4 2017.

  • Virtus Fund Advisers held 342 shares of Kyntra Bio worth $405K as of Q4 2017.
  • Kyntra Bio was a new Virtus Fund Advisers position in Q4 2017.
  • Kyntra Bio made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #349 holding.
  • 187 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.